Fairmount Funds Management LLC Argenx Se Transaction History

Fairmount Funds Management LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$338.91 - $506.01 $9.88 Million - $14.8 Million	29,156 Added 34.81%	112,903 $43 Million
Q3 2023 Nov 14, 2023	BUY	$369.35 - $548.43 $3.78 Million - $5.61 Million	10,221 Added 13.9%	83,747 $41.2 Million
Q2 2022 Aug 15, 2022	SELL	$269.58 - $378.88 $13.7 Million - $19.2 Million	-50,718 Reduced 40.82%	73,526 $27.9 Million
Q1 2022 May 16, 2022	BUY	$254.45 - $351.06 $11.6 Million - $16 Million	45,600 Added 57.98%	124,244 $39.2 Million
Q4 2021 Feb 14, 2022	BUY	$272.01 - $353.03 $5.44 Million - $7.06 Million	20,000 Added 34.1%	78,644 $27.5 Million
Q3 2021 Nov 15, 2021	SELL	$295.0 - $350.58 $3.1 Million - $3.68 Million	-10,500 Reduced 15.19%	58,644 $17.7 Million
Q2 2021 Aug 13, 2021	BUY	$257.11 - $319.92 $4.55 Million - $5.66 Million	17,694 Added 34.39%	69,144 $20.8 Million
Q1 2021 May 14, 2021	BUY	$268.3 - $380.31 $402,450 - $570,465	1,500 Added 3.0%	51,450 $14.2 Million
Q3 2020 Nov 12, 2020	SELL	$215.51 - $272.51 $107,755 - $136,255	-500 Reduced 0.99%	49,950 $13.1 Million
Q2 2020 Aug 04, 2020	SELL	$127.44 - $232.72 $3.34 Million - $6.09 Million	-26,188 Reduced 34.17%	50,450 $11.4 Million
Q1 2020 May 08, 2020	SELL	$108.83 - $165.23 $163,245 - $247,844	-1,500 Reduced 1.92%	76,638 $10.1 Million
Q4 2019 Feb 12, 2020	BUY	$106.59 - $164.21 $8.33 Million - $12.8 Million	78,138 New	78,138 $12.5 Million

400

30.9M

376K

489K

Ticker ARGX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,323,800
Market Cap $34.8B
Description
argenx SE, a biotechnology company, focuses on developing various therapies for the treatment of autoimmune diseases in the United States, the Netherlands, Belgium, Japan, Switzerland, Germany and France. Its lead product candidate is efgartigimod for the treatment of patients with myasthenia gravis, immune thrombocytopenia, pemphigus vulgaris, ...

Get notified when there are updates to the investment portfolio of Fairmount Funds Management LLC, based on Form 13F filings with the SEC.

Stay updated on Fairmount Funds Management LLC with notifications on news.